The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. | Pfizer has ...

The mRNA platform offers the advantage of faster vaccine production, which could allow more time to decide on which flu strains to cover.

The experimental mRNA vaccine prevented 60% to 67% of flu infections, while the conventional vaccine prevented 44% to 54% of ...

ACP President Dr. Jason Goldman noted that, unlike previous years, the organization did not work with the CDC on developing ...

Democratic parents are more likely than Republican parents to have high confidence in childhood vaccines’ effectiveness, ...

A new survey conducted by Pew Research Center highlights some of the biggest issues in the ongoing controversy over vaccines—and shows that politics continues to have an outsized influence on how ...

"A lot of Americans haven't even heard about this," Yam says. American's don't see COVID-19 as much as a health risk as they did before, she says, and the policy changes didn't necessary sway beliefs ...

mRNA vaccines can enhance immunotherapy efficacy by activating the immune system, improving outcomes in hard-to-treat tumors. mRNA COVID-19 vaccines enhance immune responses, improving cancer ...